Get started
Author

Richard Martin

Regulation of PPARγ coactivator 1α (PGC-1α) signaling by an estrogen-related receptor α (ERRα) ligand
2004 · Patricia J. Willy, Ian R. Murray, et al. · Proceedings of the National Academy of Sciences · 195
Identification of a Selective Inverse Agonist for the Orphan Nuclear Receptor Estrogen-Related Receptor α
2004 · Brett B. Busch, William C. Stevens,, et al. · Journal of Medicinal Chemistry · 174
Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils
2016 · Todd G. Kirchgessner, Paul Sleph, et al. · Cell Metabolism · 173
PDF
Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR)
2009 · Brenton Flatt, Richard Martin, et al. · Journal of Medicinal Chemistry · 163
Pharmacological Characterization of a Novel Liver X Receptor Agonist with Partial LXRα Activity and a Favorable Window in Nonhuman Primates
2014 · Todd G. Kirchgessner, Richard Martin, et al. · Journal of Pharmacology and Experimental Therapeutics · 48
Liver X Receptor (LXR) partial agonists: Biaryl pyrazoles and imidazoles displaying a preference for LXRβ
2014 · Ellen Kick, Richard Martin, et al. · Bioorganic & Medicinal Chemistry Letters · 46
Transdermal and transbuccal drug delivery systems: Enhancement using iontophoretic and chemical approaches
2011 · Longsheng Hu, Sérgio M.C. Silva, et al. · International Journal of Pharmaceutics · 45
Discovery of Highly Potent Liver X Receptor ? Agonists
2016 · Ellen K. Kick, Brett B. Busch, et al. · ACS Medicinal Chemistry Letters · 42
PDF
Enhanced in vitro transbuccal drug delivery of ondansetron HCl
2010 · Longsheng Hu, Bassam B. Damaj, et al. · International Journal of Pharmaceutics · 29
FXR, A Therapeutic Target for Bile Acid and Lipid Disorders
2005 · Stefan Westin, Richard Heyman, et al. · Mini-Reviews in Medicinal Chemistry · 26
Enhancing the Skin Flux of Tolnaftate Utilizing the Novel Excipient, Dodecyl-2-N,NDimethylaminopropionate (DDAIP)
2012 · Susan R. Meier-Davis, Salma Debar, et al. · Journal of Pharmaceutics & Drug Delivery Research · 2
Abstract 1297: DDAIP improves the pharmacokinetic profile of PrevOnco® in different species: Comparison of DDAIP, CMC and PEG-300/400 formulations in mice, beagle dogs and cynomolgus monkeys
2011 · Kevin Dines, Francesca Incardona, et al. · Cancer Research
Works count: 12
Citation count: 943
H-index: 10
I10-index: 10
Year
Topic
Type